BioCentury
ARTICLE | Company News

Embrex, Pfizer deal

November 20, 2006 8:00 AM UTC

PFE will acquire EMBX for $17 per share, or about $155 million in cash. The price is a 43% premium to EMBX's close of $11.92 on Nov. 14, the day before the deal was announced. EMBX sells its in ovo in...